A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors

Clinical trial NCT05389462 · TERMINATED

Trial details

NCT number: NCT05389462
Sponsor: ADC Therapeutics S.A.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2022-07-13
Primary completion: 2025-04-17
Enrollment: 128

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.